Novel quinazoline-based sulfonamide derivative (3D) induces apoptosis in colorectal cancer by inhibiting JAK2–STAT3 pathway
Introduction: Colorectal cancer (CRC) is a major worldwide health problem owing to its high prevalence and mortality rate. Developments in screening, prevention, biomarker, personalized therapies and chemotherapy have improved detection and treatment. However, despite these advances, many patient...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English English English |
Published: |
Dove Press
2018
|
Subjects: | |
Online Access: | http://irep.iium.edu.my/64779/ http://irep.iium.edu.my/64779/ http://irep.iium.edu.my/64779/1/64779-Novel%20quinazoline-based.pdf http://irep.iium.edu.my/64779/2/64779-Novel%20quinazoline-based%20SCOPUS.pdf http://irep.iium.edu.my/64779/13/64779_Novel%20quinazoline-based%20sulfonamide%20derivative%20%283D%29%20induces%20apoptosis%20in%20colorectal%20cancer%20by%20inhibiting%20JAK2-STAT3%20pathway_WOS.pdf |
Summary: | Introduction: Colorectal cancer (CRC) is a major worldwide health problem owing to its high
prevalence and mortality rate. Developments in screening, prevention, biomarker, personalized
therapies and chemotherapy have improved detection and treatment. However, despite these
advances, many patients with advanced metastatic tumors still succumb to the disease. New
anticancer agents are needed for treating advanced stage CRC as most of the deaths occur due to
cancer metastasis. A recently developed novel sulfonamide derivative 4-((2-(4-(dimethylamino)
phenyl)quinazolin-4-yl)amino)benzenesulfonamide (3D) has shown potent antitumor effect;
however, the mechanism underlying the antitumor effect remains unknown.
Materials and methods: 3D-mediated inhibition on cell viability was evaluated by MTT and
real-time cell proliferation was measured by xCelligence RTDP instrument. Western blotting
was used to measure pro-apoptotic, anti-apoptotic proteins and JAK2-STAT3 phosphorylation.
Flow cytometry was used to measure ROS production and apoptosis.
Results: Our study revealed that 3D treatment significantly reduced the viability of human CRC
cells HT-29 and SW620. Furthermore, 3D treatment induced the generation of reactive oxygen
species (ROS) in human CRC cells. Confirming our observation, N-acetylcysteine significantly
inhibited apoptosis. This is further evidenced by the induction of p53 and Bax; release of cytochrome
c; activation of caspase-9, caspase-7 and caspase-3; and cleavage of PARP in 3D-treated cells. This
compound was found to have a significant effect on the inhibition of antiapoptotic proteins Bcl2 and
BclxL. The results further demonstrate that 3D inhibits JAK2–STAT3 pathway by decreasing the
constitutive and IL-6-induced phosphorylation of STAT3. 3D also decreases STAT3 target genes
such as cyclin D1 and survivin. Furthermore, a combination study of 3D with doxorubicin (Dox)
also showed more potent effects than single treatment of Dox in the inhibition of cell viability.
Conclusion: Taken together, these findings indicate that 3D induces ROS-mediated apoptosis
and inhibits JAK2–STAT3 signaling in CRC. |
---|